Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.
Subscribe to:
Post Comments (Atom)
< + > Connected Care and Lessons Learned from Consumer Trends in Retail Can Help Clinicians Meet Patient Expectations
The following is a guest article by Lucienne Ide , MD, PhD, Founder and CEO at Rimidi The retail industry’s longstanding commitment to mee...
No comments:
Post a Comment